ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 329250 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 329250; 2) Community: the network communities that were significantly associated with the response to NSC 329250; 3) Molecule: the relationships between components within communities and NSC 329250; 4) MDR: the compounds that were significantly associated with the NSC 329250.

NSC Compound Enrichment Correlation
NSC 751830 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one 0.0438391811600412 0.038952556
NSC 7534 SCILLIROSIDIN, GLYCOSIDE 0.0438391811600412 0.1150227
NSC 758662 Lovastatin [USAN] 0.0438391811600412 -0.0025232057
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.045446901295916 -0.1156106
NSC 630994 Null 0.045446901295916 0.20272491
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.045446901295916 0.11495714
NSC 659319 Null 0.045446901295916 -0.15685694
NSC 665700 Null 0.045446901295916 -0.076266696
NSC 682829 Propanimidoyl chloride, 2-methyl-N-[[[[4-(methoxy- carbonyl)phenyl]amino]carbonyl]oxy]- 0.045446901295916 -0.0095345529
NSC 683787 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-methyl- 0.045446901295916 0.077654532
Total:32  Current:26    [First] [Prev] [Next] [Last]